Andrew Darke
12Patents
8h-index
5Co-inventors
61Inventor score
Filing activity: Dec 16, 1999 → Sep 25, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6419960B1 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Human Necessities | 128 | Expired |
| US6673367B1 | Controlled/modified release oral methylphenidate formulations | Human Necessities | 69 | Expired |
| US7083808B2 | Controlled/modified release oral methylphenidate formulations | Human Necessities | 65 | Expired |
| US7247318B2 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Human Necessities | 22 | Expired |
| US7438930B2 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Human Necessities | 20 | Active |
| US8580310B2 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Human Necessities | 16 | Active |
| US9066869B2 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Human Necessities | 13 | Active |
| US9801823B2 | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations | Human Necessities | 13 | Active |
| US9949931B2 | Methods of treating attention deficit hyperactivity disorder | Human Necessities | 0 | Active |
| US10022330B2 | Methods of preparing oral controlled release formulations | Human Necessities | 0 | Active |
| US10463624B2 | Controlled release formulations | Human Necessities | 0 | Active |
| US10039719B2 | Methods of treating attention deficit hyperactivity disorder | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.